EU drug watchdog reaffirms no particular clot risk factor linked to AstraZeneca vaccine

(Reuters) - Europe's medicines regulator reiterated its backing of AstraZeneca's COVID-19 vaccine, saying no particular group of age, sex or a previous medical history was especially susceptible to blood clotting after receiving the shot.

Reuters April 01, 2021 00:11:07 IST
EU drug watchdog reaffirms no particular clot risk factor linked to AstraZeneca vaccine

EU drug watchdog reaffirms no particular clot risk factor linked to AstraZeneca vaccine

(Reuters) - Europe's medicines regulator reiterated its backing of AstraZeneca's COVID-19 vaccine, saying no particular group of age, sex or a previous medical history was especially susceptible to blood clotting after receiving the shot.

However, while repeating that the vaccine's benefits outweigh risks, it cautioned that people should be aware of the "remote possibility" of rare blood clots occurring, and must seek immediate medical attention in case of symptoms.

"A causal link with the vaccine is not proven, but is possible and further analysis is continuing," the European Medicines Agency (EMA) said in a statement. (https://bit.ly/3m6d2M9)

EMA issued the statement after a hearing with a panel of independent external experts on Monday.

It spoke after several countries including Canada, Germany, France and Spain limited use of the drugmaker's shot, after reports of a rare clotting condition following vaccination.

Investigations by EMA and several national authorities in the EU continue, after initial probes deemed the vaccine safe for use following reports of a brain clotting ailment known as cerebral venous sinus thrombosis (CVST).

A high proportion among the reported cases affected young and middle-aged women but that did not lead EMA to conclude this cohort was particularly at risk from AstraZeneca's shot.

Women were generally more prone to CVST than men and twice as many women as men had received AstraZeneca's shot in the EU so far, said EMA's head of safety monitoring, Peter Arlett.

"This is why at this stage it is difficult to disentangle why there has been a preponderance of reports of this very rare potential side effect in younger women in particular," he added.

EMA had analysed 62 such cases globally, consulting also with regulators in India, Brazil and Britain, and 44 of the cases had occurred in the European Economic Area (EEA).

It had looked into 14 deaths, though not all were associated with CVST, said Arlett. About 9.2 million people in the EEA had received the shot by the assessment's cut-off date of March 22.

Arlett did acknowledge the blood-clotting incidence rate was higher than what was normally expected in the young and middle-aged. Though he did not quantify the difference, he said it did not justify a change in recommendation.

"If we look into individuals under 60, we do see more cases of (CVST) than we would expect to see from the background rate," said Arlett.

Germany vaccine oversight body PEI said on Tuesday it had registered 31 cases of CVST, which resulted in nine deaths, out of some 2.7 million people who have received the AstraZeneca vaccine.

EMA said a few of the German cases happened after its cut-off date and had not yet been included in its analysis.

(Reporting by Pushkala Aripaka in Bengaluru, Ludwig Burger in Frankfurt, Josephine Mason in London; Editing by Shinjini Ganguli, Rashmi Aich and Mark Heinrich)

This story has not been edited by Firstpost staff and is generated by auto-feed.

Updated Date:

TAGS:

also read

Amazon union vote enters final stretch in watershed moment for U.S. labour
Business

Amazon union vote enters final stretch in watershed moment for U.S. labour

By Mike Spector and Jeffrey Dastin (Reuters) - The National Labor Relations Board has begun reviewing ballots from Amazon.com Inc's workers in Alabama, who have voted on whether to form a union, with momentum for future labour organizing at America's second-largest private employer hanging in the balance. Agents from the labour board began sifting through ballots sent to more than 5,800 workers at Amazon's Bessemer, Alabama-based warehouse at 10 a.m

Spotify buys Locker Room app's maker Betty Labs in live audio push
News & Analysis

Spotify buys Locker Room app's maker Betty Labs in live audio push

By Elizabeth Culliford NEW YORK (Reuters) - Spotify Inc said on Tuesday it has purchased Betty Labs, the company behind sports-focused social audio app Locker Room, to accelerate its move into live audio. New voice-based platforms, including invite-only social app Clubhouse, have seen rapid growth in recent months during the COVID-19 pandemic.

Oil falls as Suez Canal opens, dollar rallies; eyes on OPEC+ meeting
Business

Oil falls as Suez Canal opens, dollar rallies; eyes on OPEC+ meeting

By Devika Krishna Kumar NEW YORK (Reuters) - Oil prices slid on Tuesday as the Suez Canal reopened to traffic and the dollar rallied, while focus turned to an OPEC+ meeting this week, where analysts expect an extension to supply curbs to offset dim demand prospects. Brent crude fell $1.20, or 1.9%, at $63.78 a barrel by 1:12 p.m.